BackGenetic Technologies Overview

Genetic Technologies EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GENE.

Quarterly EBIT

-$7.05M
53.94% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$19.38M
29.96% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)